Home - Products - Angiogenesis - EGFR - (1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine

(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine

CAS No. 146504-07-6

(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine( —— )

Catalog No. M18038 CAS No. 146504-07-6

Cyclohexanediamine has a potential of anticancer activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 27 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine
  • Note
    Research use only, not for human use.
  • Brief Description
    Cyclohexanediamine has a potential of anticancer activity.
  • Description
    Cyclohexanediamine has a potential of anticancer activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    146504-07-6
  • Formula Weight
    214.31
  • Molecular Formula
    C11H22N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)(C)OC(=O)N[C@@H]1CCCC[C@H]1N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • WHI-P258

    WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.

  • EGFR-IN-11

    EGFR-IN-11 is a selective inhibitor of EGFR-tyrosine kinase and induces cell apoptosis. EGFR-IN-11 inhibits triple mutant EGFRL858R/T790M/C797S with an IC50 of 18 nM and arrests cell cycle at G0/G1.

  • Sunvozertinib

    Sunvozertinib (DZD9008) is a potent ErbBs and BTK inhibitor, with inhibitory effects on EGFR, Her2, and mutant epidermal growth factor.